Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 81.41% | -3,086.62% | -4,163.16% | -557.44% | -574.87% |
| Total Depreciation and Amortization | -14.51% | -12.64% | 23.98% | 27.03% | 29.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -78.54% | 4,925.51% | 7,390.77% | 511.70% | 535.29% |
| Change in Net Operating Assets | -42.29% | 355.97% | 341.33% | 251.09% | 190.67% |
| Cash from Operations | -25.82% | 88.11% | 84.09% | 330.77% | 210.80% |
| Capital Expenditure | -77.53% | -56.08% | -60.38% | -45.71% | -28.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -1,247.62% | -- | -- | -- |
| Divestitures | -- | -102.31% | -100.00% | -102.31% | -100.00% |
| Other Investing Activities | 48.45% | 38.89% | -880.95% | -- | -- |
| Cash from Investing | -120.36% | -200.49% | -273.14% | -246.61% | -227.31% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | 35.82% | 51.75% | 36.01% | 36.83% | 55.22% |
| Issuance of Common Stock | -36.36% | -36.36% | 100.00% | 100.00% | 83.33% |
| Repurchase of Common Stock | 74.22% | 83.77% | 83.16% | 67.40% | -26.73% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 72.95% | 72.95% | 67.52% |
| Cash from Financing | 24.64% | 54.77% | -2.71% | -6.46% | 47.88% |
| Foreign Exchange rate Adjustments | 221.95% | -88.24% | 2,400.00% | -266.67% | -327.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.50% | -2.21% | -118.27% | 206.53% | 150.00% |